Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

A comprehensive laboratory protocol and analysis workflow are described for a rapid, cost-effective, and straightforward colorimetric cell-based assay to detect neutralizing elements against AAV6.

Abstract

Recombinant adeno-associated viruses (rAAV) have proven to be a safe and successful vector for transferring genetic material to treat various health conditions in both the laboratory and the clinic. However, pre-existing neutralizing antibodies (NAbs) against AAV capsids pose an ongoing challenge for the successful administration of gene therapies in both large animal experimental models and human populations. Preliminary screening for host immunity against AAV is necessary to ensure the efficacy of AAV-based gene therapies as both a research tool and as a clinically viable therapeutic agent. This protocol describes a colorimetric in vitro assay to detect neutralizing factors against AAV serotype 6 (AAV6). The assay utilizes the reaction between an AAV encoding an alkaline phosphatase (AP) reporter gene and its substrate NBT/BCIP, which generates an insoluble quantifiable purple stain upon combination.

In this protocol, serum samples are combined with an AAV expressing AP and incubated to permit potential neutralizing activity to occur. Virus serum mixture is subsequently added to cells to allow for viral transduction of any AAVs that have not been neutralized. The NBT/BCIP substrate is added and undergoes a chromogenic reaction, corresponding to viral transduction and neutralizing activity. The proportion of area colored is quantitated using a free software tool to generate neutralizing titers. This assay displays a strong positive correlation between coloration and viral concentration. Assessment of serum samples from sheep before and after administration of a recombinant AAV6 led to a dramatic increase in neutralizing activity (125 to >10,000-fold increase). The assay displayed adequate sensitivity to detect neutralizing activity in >1:32,000 serum dilutions. This assay provides a simple, rapid, and cost-effective method to detect NAbs against AAVs.

Introduction

Adeno-associated viruses (AAV) are increasingly used as vectors for the delivery of gene therapies to trial treatments for various health conditions that impact the cardiovascular, pulmonary, circulatory, ocular, and central nervous systems1,2,3,4,5. The popularity of AAV vectors as a leading gene therapy platform stems from their positive safety profile, long-term transgene expression, and wide-ranging tissue-specific tropisms1,6. Successful outcom....

Protocol

All aspects of animal care and experimentation were conducted following Florey Institute of Neuroscience and Mental Health guidelines and the Australian Code for the Care and Use of Animals for Scientific Purposes following Reference25. 1.5-3-year-old Merino ewes were used for the study. A schematic overview of the assay protocol is provided in Figure 1.

Representative Results

Transduction assay to establish the optimal viral dosage for plate coverage
HT1080 cells, a well-established fibrosarcoma cell line, were selected for this assay. A concentration of 1 x 104 HT1080 cells/well provided ~50% cell confluency in each well of a 96-well plate. To determine the optimal viral concentration for the assay, an rAAV encoding an hPLAP (human placental alkaline phosphatase) reporter gene (AAV6-hPLAP)31 was added in triplicate at a range of conce.......

Discussion

This report describes a colorimetric assay that assesses the extent of AAV neutralization in a given serum sample by evaluating a chromogenic reaction corresponding to the degree of in vitro viral transduction. The development of the protocol was based on the known chromogenic reaction between the enzyme alkaline phosphatase and NBT/BCIP, which has been widely utilized as a staining tool for the detection of protein targets in applications such as immunohistochemistry and as a reporter tool for evaluating viral .......

Acknowledgements

This study was funded by a National Health and Medical Research Council Project Grant to JRM and CJT (ID 1163732) and in part by the Victorian Government's Operational Infrastructure Support Program. SB is supported by a joint Baker Heart and Diabetes Institute-La Trobe University Doctoral Scholarship. KLW is supported by The Shine On Foundation and a Future Leader Fellowship from the National Heart Foundation of Australia (ID 102539). JRM is supported by a National Health and Medical Research Council Senior Research Fellowship (ID 1078985).

....

Materials

NameCompanyCatalog NumberComments
0.05% Trypsin/EDTAGibco25300-054
50 mL conical centrifuge tubeFalcon14-432-22Or equivalent
75 cm2 square flasksFalcon353136Or equivalent
96 well flat bottomed plateFalcon353072
AAV6-CMV-hPLAP VectorMuscle Research & Therapeutics Lab (University of Melbourne, Australia) AAV6-CMV-hPLAP can be provided upon request.
Aluminium foil
Anti-AAV6 (intact particle) mouse monoclonal antibody, (ADK6)PROGEN610159Positive control monoclonal antibody
BCIP/NBTSIGMAFASTB5655
Cell and tissue culture safety cabinet
Electronic Pipette5 & 10 mL stripette inserts
Fetal Bovine SerumGibco10099-141
Haemocytometer
High glucose Dulbecco's Modified Eagle Medium (DMEM)Gibco11965118
HT1080 cellsATCC
ImageJ SoftwareFreely available: https://imagej.nih.gov/ij/download.html
Incubator37 °C, 5% CO2
Light microscope with cameraCapable of taking photos with a 4x objective lens
OvenFor a 65 °C incubation
ParaformaldehydeMERCK30525-89-4
Penicillin StreptomycinGibco15140-122
Phosphate buffered saline
Pipettes and tips20 μL, 200 μL & 1 mL single pipettes and tips & 200 μL multichannel pipette
Stericup quick release filterMilliporeS2GPU10REUsed for combining media reagents
Trypan blue solutionSigma-AldrichT8154
VACUETTE TUBE 8 ml CAT Serum Separator Clot ActivatorGreiner BIO-ONE455071Used for serum collection & processing from sheep
Water bath

References

  1. Bass-Stringer, S., et al. Adeno-associated virus gene therapy: Translational progress and future prospects in the treatment of heart failure. Heart, Lung and Circulation. 27 (11), 1285-1300 (2018).
  2. Casey, G. A., Papp, K. M., MacDonald, I. M.

Explore More Articles

Neutralizing AntibodiesAAV Gene TherapyColorimetric Cell based AssayHT1080 CellsSerum DilutionsViral GenomeParaformaldehydeAlkaline PhosphataseBCIP NBTMicroscopy

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved